Association of toll-like receptors polymorphisms with COPD risk in Chinese population
Background: Previous studies have reported that the Toll-like receptors (TLRs) are related with the progress of chronic obstructive pulmonary disease (COPD). We aimed to explore the association of TLRs single nucleotide polymorphisms (SNPs) and COPD risk. Methods: 170 COPD patients and 181 healthy c...
Gespeichert in:
Veröffentlicht in: | Frontiers in genetics 2022-10, Vol.13, p.955810-955810 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background:
Previous studies have reported that the Toll-like receptors (TLRs) are related with the progress of chronic obstructive pulmonary disease (COPD). We aimed to explore the association of TLRs single nucleotide polymorphisms (SNPs) and COPD risk.
Methods:
170 COPD patients and 181 healthy controls were enrolled in this case-control study. MassARRAY platform was used for genotyping seven tagging SNPs (
TLR2
: rs3804100, rs4696480, rs3804099;
TLR3
: rs3775290, rs3775291, rs5743305;
TLR9
: rs352140) of TLRs. The correlations between the SNPs and COPD risk were determined using logistic regression.
Results:
We found that the rs3775291 of
TLR3
significant decreased the risk of COPD (TT
versus
CC: non-adjusted OR = 0.329, 95% CI = 0.123–0.879,
p
= 0.027). In the genetic models analysis, the rs3775291 was associated with a decreased effect of COPD based on the recessive model (TT
versus
CC/CT: non-adjusted OR = 0.377, 95% CI = 0.144–0.988
p
= 0.047). The rs4696480 of
TLR2
gene was associated with a decreased risk of COPD after adjustment by age and gender (TA
versus
AA: adjusted OR = 0.606, 95% CI = 0.376–0.975,
p
= 0.039).
Conclusion:
Our study showed that genetic variants in
TLRs
were associated with risk of COPD. The rs3775291 and rs4696480 may act as a potential biomarker for predicting the risk of COPD in Chinese population. |
---|---|
ISSN: | 1664-8021 1664-8021 |
DOI: | 10.3389/fgene.2022.955810 |